Semi-Annual Consolidated Statement Of Cash Flows

Chordia Therapeutics,Inc - Filing #7315839

Concept 2023-09-01 to
2024-05-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-1,175,664,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.